3Khan MA, Walling T, Cumpston A, et al. CMV colitis in a patient receiving dasatinib [ J ]. Blood, 2007, 110 (13) :213.
4R. Garcia Mufioz, E. Ruiz de Gaona, P. Rodriguez Ote- ro, et al. Reactivation of herpes virus-6 in a chronic my- eloyd leukemia (CML) patient during treatment with da- satinib [ J ]. Haematologiea, 2007, 92 ( Suppl 2 ) :493.
5Bergeron A, Rea D, Levy V, et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series[J]. Am J Respir Crit Care Med, 2007, 176 (8) :814-818.
6Radaelli F, Bramanti S, Fantini NN, et al. Dasatinib- related alveolar pneumonia responsive to corticosteroids ~J]. Leuk Lymphoma, 2006, 47(6):1180-1181.
7Rasheed W, Flaim B, Seymour JF, et al. Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia [ J ]. Leuk Res, 2009, 33 ( 6 ) : 861- 864.
8Mattei D, Feola M, Orzan F, et al. Reversible dasatinib-induced pulmonary arterial hypertension and fight ventricle failure in a previously allografted CML patient[ J ]. Bone Marrow Transplant, 2009, 43(12): 967-968.
9Montani D, Bergot E, GUnther S, et al. Pulmonary arterial hypertension in patients treated by dasatinib [ J ]. Circulation, 2012, 125(17) :2128-2137.
10Hennigs JK, Keller G, Baumann HJ, et al. Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? [J]. BMC Pulm Med, 2011, 11:30.
